The gene encoding the melanin-concentrating hormone receptor 1 is associated with schizophrenia in a Danish case-control sample

Psychiatric Genetics

Volumn 22, Issue 2, 2012, Pages 62-69

  Demontis, Ditte ^a   Nyegaard, Mette ^a,b   Christensen, Jane H ^a   Severinsen, Jacob ^a   Hedemand, Anne ^a   Hansen, Thomas ^c   Werge, Thomas ^c   Mors, Ole ^d   Børglum, Anders D ^a,d  

^a AARHUS UNIVERSITY   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c Mental Health Center Glostrup   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

22q13; antipsychotic treatment; association; GPR24; MCHR1; schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; MELANIN CONCENTRATING HORMONE RECEPTOR 1;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 22; DENMARK; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, SOMATOSTATIN; SCHIZOPHRENIA;

EID: 84858152876     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32834dc424     Document Type: Article

References (49)

1. Adamantidis A, Thomas E, Foidart A, Tyhon A, Coumans B, Minet A, et al. (2005). Disrupting the melanin-concentrating hormone receptor 1 in mice leads to cognitive deficits and alterations of NMDA receptor function. Eur J Neurosci 21:2837-2844.
2. Borowsky B, Durkin MM, Ogozalek K, Marzabadi MR, DeLeon J, Lagu B, et al. (2002). Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med 8:825-830.
3. Chaki S, Funakoshi T, Hirota-Okuno S, Nishiguchi M, Shimazaki T, Iijima M, et al. (2002). Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists. J Pharmacol Exp Ther 313:831-839. (Pubitemid 40604185)
4. Condra JA, Neibergs H, Wei W, Brennan MD (2007). Evidence for two schizophrenia susceptibility genes on chromosome 22q13. Psychiatr Genet 17:292-298. (Pubitemid 47345751)
5. David DJ, Klemenhagen KC, Holick KA, Saxe MD, Mendez I, Santarelli L, et al. (2007). Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy) phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. J Pharmacol Exp Ther 321:237-248. (Pubitemid 46456989)
6. Di Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D (2005). Efficiency and power in genetic association studies. Nat Genet 37: 1217-1223. (Pubitemid 41568704)
7. Epstein J, Stern E, Silbersweig D (1999). Mesolimbic activity associated with psychosis in schizophrenia: sympton-specific PET studies. Ann N Y Acad Sci 877:562-574. (Pubitemid 29351879)
8. Excoffier L, Laval G, Schneider S (2005). Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol Bioinfo Online 1:47-50.
9. Fisher AR (1925). Statistical methods for research workers. London: Oliver and Boyd.
10. Gehlert DR, Rasmussen K, Shaw J, Li X, Ardayfio P, Craft L, et al. (2009). Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression. J Pharmacol Exp Ther 329:429-438.
11. Georgescu D, Sears RM, Hommel JD, Barrot M, Bolaños CA, Marsh DJ, et al. (2005). The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbus to modulate feeding behavior and forced-swim performance. J Neurosci 25:2933-2940. (Pubitemid 40389251)
12. Guesdon B, Raphaël GPD, Richard D (2010). Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance. Behav Brain Res 207:14-20.
13. Hansen T, Jakobsen KD, Fenger M, Nielsen J, Krane K, Fink-Jensen A, et al. (2008). Variation in the purinergic P2RX7 receptor gene and schizophrenia. Schizophr Res 104:146-152.
14. Hansen T, Hemmingsen RP,Wang AG, Olsen L, Timm S, Søeby K, et al. (2006). Apolipoprotein D is associated with long-term outcome in patients with schizophrenia. Pharmacogenomics J 6:120-125.
15. Harrison PJ, Weinberger DR (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10:40-68. (Pubitemid 40139588)
16. International Schizophrenia Consortium (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
17. Jakobsen KD, Frederiksen JN, Parnas J,Werge T (2006). Diagnostic agreement of schizophrenia spectrum disorders among chronic patients with functional psychoses. Psychopathology 39:269-276. (Pubitemid 44492192)
18. Jorgensen TH, Børglum AD, Mors O,Wang AG, Pinaud M, Flint TJ, et al. (2002). Search for common haplotypes on chromosome 22q in patients with schizophrenia or bipolar disorder from the Faroe Islands. Am J Med Genet 114:245-252. (Pubitemid 34160479)
19. Knight HM, Maclean A, Irfan M, Naeem F, Cass S, Pickard BS, et al. (2008). Homozygosity mapping in a family presenting with schizophrenia, epilepsy and hearing impairment. Eur J Hum Genet 16:750-758. (Pubitemid 351753372)
20. Li J, Ji L (2005). Adjusting multiple testing in multilocus analyses using the Eigen values of a correlation matrix. Heredity 95:221-227. (Pubitemid 43093236)
21. Li Y, Abecasis GR (2006). MACH 1.0: rapid haplotype reconstruction and missing genotype inference. Am J Hum Genet S79:2290.
22. Lin PI, Vance JM, Pericak-Vance MA, Martin ER (2007). No gene is an island: the flip-flop phenomenon. Am J Hum Genet 80:531-538.
23. Marsh DJ, Weingarth DT, Novi DE, Chen HY, Trumbauer ME, Chen AS, et al. (2002). Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphegic and have altered metabolism. PNAS 99: 3240-3245. (Pubitemid 34240616)
24. Menashe I, Rosenberg PS, Chen BE (2008). PGA: power calculator for case-control genetic association analysis. BMC Genet 9:36.
25. Millan MJ, Gobert A, Panayi F, Rivert JM, Dekeyne A, Brocco M, et al. (2008). The melanin-concentrating hormone1, receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the frontal cortex of rats. Int J Neuropsychopharmacol 11: 1105-1122.
26. Miller CL, Murakami P, Ruczinski I, Ross RG, Sinkus M, Sullivan B, et al. (2009). Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder. Schizophr Res 113:259-267.
27. Nyegaard M, Severinsen JE, Als TD, Hedemand A, Straarup S, Nordentoft M, et al. (2010). Support of association between BRD1 and both schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 153B:582-591.
28. Nyholt DR (2004). A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765-769.
29. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, et al. (2008). Identification of novel schizophrenia loci by genome-wide association and followup. Nat Genet 40:1053-1055.
30. Pennington K, Beasley CL, Dicker P, Fagan A, English J, Pariante CM, et al. (2008). Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry 13:1102-1117.
31. Pissios P, Frank L, Kennedy AR, Porter DR, Marino FE, Liu F, et al. (2008). Dysregulation of the mesolimbic dopamine system and reward in MCH-/- mice. Biol Psychiatry 64:184-191.
32. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. (2007). PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 81:559-575. (Pubitemid 47330214)
33. Roy M, David N, Cueva M, Giorgetti M (2007). A study of the involvement of melanin-concentrating hormone receptor 1(MCHR1) in murine models of depression. Biol Psychiatry 61:174-180. (Pubitemid 46072783)
34. Severinsen JE, Als TD, Binderup H, Kruse TA, Wang AG, Vang M, et al. (2006). Association analysis suggest GPR24 as a shared susceptibility gene for bipolar affective disorder and schizophrenia. Am J Med Genet Part B 141B:524-533. (Pubitemid 44024447)
35. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, et al. (2009). Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460:753-757.
36. Shifman S, Johannesson M, Bronstein M, Chen SX, Collier DA, Craddock NJ, et al. (2008). Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 4:e28.
37. Shimizu M, Fujiwara H, Hirao K, Namiki C, Fukuyama H, Hayashi T, et al. (2008). Structural abnormalities of adhesion interthalamica and mediodorsal nuclei of the thalamus in schizophrenia. Schizophr Res 101:331-338.
38. Shin HD, Park BL, Kim EM, Lee SO, Cheong HS, Lee CH, et al. (2007). Association analysis of G72/G30 polymorphisms with schizophrenia in the Korean population. Schizophr Res 96:119-124. (Pubitemid 47500143)
39. Smith DG, Tzavara ET, Shaw J, Luecke S, Wade M, Davis R, et al. (2005). Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J Neurosci 25:914-922. (Pubitemid 40171007)
40. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al. (2009). Common variants conferring risk of schizophrenia. Nature 460:744-747.
41. Sullivan PF (2007). Spurious genetic associations. Biol Psychiatry 61:1121-1126.
42. Takahashi S, Faraone SV, Lasky-Su J, Tsuang MT (2005). Genome-wide scan of homogeneous subtypes of NIMH genetics initiative schizophrenia families. Psychiatry Res 133:111-122. (Pubitemid 40312145)
43. Tan EC, Chong SA, Wang H, Lim ECP, Teo YY (2005). Gender-specific association of insertion/deletion polymorphisms in the nogo gene and chronic schizophrenia. Mol Brain Res 139:212-216. (Pubitemid 41317933)
44. The International Schizophrenia Consortium (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748-752.
45. The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011). Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43: 969-976.
46. Thiselton DL, Vladimirov VI, Kuo PH, McClay J, Wormley B, Fanous A, et al. (2008). AKT1 is associated with schizophrenia across multiple symptom dimensions in the irish study of high density schizophrenia families. Biol Psychiatry 63:449-457. (Pubitemid 351220788)
47. Voineskos AN, de LV, Bulgin NL, Van AQ, Shaikh S, Lang DJ, et al. (2008). A family-based association study of the myelin-associated glycoprotein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase genes with schizophrenia. Psychiatr Genet 18:143-146.
48. Wermter AK, Reichwald K, Büch T, Geller F, Platzer C, Huse K, et al. (2005). Mutation analysis of the MCHR1 gene in human obesity. Eur J Endocrinol 152:851-862. (Pubitemid 40903575)
49. Williams NM, Glaser B, Norton N,Williams H, Pierce T, Moskvina V, et al. (2008). Strong evidence that GNB1L is associated with schizophrenia. Hum Mol Genet 17:555-566. (Pubitemid 351201768)